SPM 4946
Alternative Names: SPM 3672Latest Information Update: 21 Aug 2001
At a glance
- Originator Schwarz Pharma
- Class Ischaemic heart disorder therapies; Organic nitrates; Vasodilators
- Mechanism of Action Guanylate cyclase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Angina pectoris
Most Recent Events
- 21 Aug 2001 Discontinued-Preclinical for Angina pectoris in Germany (Unknown route)